Repare Therapeutics shares are trading higher after the company agreed to sell a cancer drug asset to Gilead Sciences for up to $30 million.

Repare Therapeutics 0.00%

Repare Therapeutics

RPTX

2.58

0.00%

Repare Therapeutics shares are trading higher after the company agreed to sell a cancer drug asset to Gilead Sciences for up to $30 million.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via